Advertisement

Topics

VALNEVA Reports Strong 2017 Revenues Driven by Double Digit Product Sales Growth

02:00 EST 15 Feb 2018 | GlobalNewsWire (2014)

This article has expired, however you can still download the PDF.
Preview:
Valneva Reports Strong 2017 Revenues Driven by Double Digit Product Sales Growth Strong sales performance in 2017 (unaudited) Total revenues of €109.8 million in 2017 (2016 - €97.9 million) representing year-on-year growth of 12% Product s...

Other Sources for this Article

NEXT ARTICLE

More From BioPortfolio on "VALNEVA Reports Strong 2017 Revenues Driven by Double Digit Product Sales Growth "

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Clincial Trials
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...